Research Grants

Delahanty, Terence, 4-H Central Operations, Positive Youth Development State and Local Collaboration Demonstration Project, $59,221,

Delahanty, Terence, 4-H Central Operations, Positive Youth Development State and Local Collaboration Demonstration Project, $1,034,

Delahanty, Terence, 4-H Central Operations, Positive Youth Development State and Local Collaboration Demonstration Project, $42,062,

Delahanty, Terence, 4-H Central Operations, Positive Youth Development State and Local Collaboration Demonstration Project, $16,083,

Delahanty, Terence, 4-H Central Operations, Positive Youth Development State and Local Collaboration Demonstration Project, $1,600,

Dwoskin, Linda, Pharmaceutical Tech, Drug Abuse Prevention: A Lifecourse Perspective IV-Project 1, $27,104,

Dwoskin, Linda, Pharmaceutical Tech, Drug Abuse Prevention: A Lifecourse Perspective IV-Project 1, $1,500,

Dwoskin, Linda, Pharmaceutical Tech, Drug Abuse Prevention: A Lifecourse Perspective IV-Project 1, $47,701,

Dwoskin, Linda, Pharmaceutical Tech, Drug Abuse Prevention: A Lifecourse Perspective IV-Project 1, $11,300,

Kelly, Thomas, Behavioral Science, Drug Abuse Prevention: A Lifecourse Perspective IV-Project 2, $46,882,

Kelly, Thomas, Behavioral Science, Drug Abuse Prevention: A Lifecourse Perspective IV-Project 2, $176,374,

Kelly, Thomas, Behavioral Science, Drug Abuse Prevention: A Lifecourse Perspective IV-Project 2, $98,532,

Kelly, Thomas, Behavioral Science, Drug Abuse Prevention: A Lifecourse Perspective IV-Project 2, $1,500,

Lynam, Donald, Psychology, , Drug Abuse Prevention: A Lifecourse Perspective IV-Project 3, $46,620,

Lynam, Donald, Psychology, , Drug Abuse Prevention: A Lifecourse Perspective IV-Project 3, $95,041,

Lynam, Donald, Psychology, , Drug Abuse Prevention: A Lifecourse Perspective IV-Project 3, $0,

Lynam, Donald, Psychology, , Drug Abuse Prevention: A Lifecourse Perspective IV-Project 3, $3,500,

Lynam, Donald, Psychology, , Drug Abuse Prevention: A Lifecourse Perspective IV-Project 3, $17,322,

McDonagh, Kevin, Int Med - Hema/Onc, A Randomized Open-label Study of 400 mg Versus 800 mg of Gleevac/Gilvac (imatinab mesylate) in patients with newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP) using Molecular Endpoints, $1,

Mumper, Russell, Pharmaceutical Science & Tech, cGMP Manufacture of Freeze-Dried Black Rasberry Gel, $11,076,

Mumper, Russell, Pharmaceutical Science & Tech, cGMP Manufacture of Freeze-Dried Black Rasberry Gel, $23,924,

Perrier, Donald, Pharmacy Practice & Science, Performance Measurement System, $25,200,

Perrier, Donald, Pharmacy Practice & Science, Performance Measurement System, $464,730,

Perrier, Donald, Pharmacy Practice & Science, Performance Measurement System, $124,310,

Perrier, Donald, Pharmacy Practice & Science, Performance Measurement System, $11,000,

Perrier, Donald, Pharmacy Practice & Science, Performance Measurement System, $159,703,

Reed, Michael, International Programs, Technical Assistance to Romanian Agriculture

Rinehart, John, Int Med - Hema/Onc, Randomized Phase III Trail of Leukine vs Newpogen in Patients Receiving Cisplatin and Gemcitabine for Reionally Advanced or Metastatic Urothelial Cancer, $1,

Saito, Kozo, Mechanical Engineering, Carbon Nanotube Synthesis and Application, $34,176,

Saito, Kozo, Mechanical Engineering, Carbon Nanotube Synthesis and Application, $15,824,

Smith, Gregory, Psychology, Longitudinal & Experiemental Analysis of Positive Urgency

Stocker, Sean, Physiology, , Forebrain Neurohumoral Integration in Heart Failure